Cockett MI, Birch ML, Murphy G., Hart IR, Docherty AJ (1994). Metalloproteinase domain structure, cellular invasion and metastasis. Biochem Soc Trans22:55-57.
2.
Frye CA, Yocum DE, Tuan RS, Suyana E., Seftor EA, Seftor Reb, et al. (1996). An in vitro model for studying mechanisms underlying synoviocyte-mediated cartilage destruction in rheumatoid arthritis , Path Oncol Res2 :157-166.
3.
Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991). Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med2:297-321.
4.
Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS (1994). A nonantimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann NYAcad Sci732:96-111.
5.
Hendrix Mjc, Seftor EA, Seftor Reb, Fidler IJ (1987). A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett38:137-147.
6.
Himelstein BP, Canete-Solar R., Bernhard EJ, Dilks DW, Muschel RJ (1994). Metalloproteinases in tumor progression: the contribution of MMP-9. Inv Metast14:246-258.
7.
Kohn EC, Liotta LA (1995). Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res55:1856-1862.
8.
Lim YT, Sugiura Y., Laug WE, Sun B., Garcia A., DeClerck YA (1996). Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. J Cell Physiol167:333-340.
9.
Liotta LA, Rao CN, Wewer UM (1986). Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem55:1037-1057.
10.
Nip LH, Uitto V-J.Golub LM (1993). Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodont Res28:379-385.
11.
Noel A., Emonard H., Pollette M., Birembaut P., Foidart JM (1994). Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Path Res Pract190:934-941.
12.
Rifkin BR, Vernillo AT, Golub LM (1993). Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. Am Acad Periodontol64:819-827.
13.
Rifkin BR, Vernillo AT, Golub LM, Ramamurthy NS (1994). Modulation of bone resorption by tetracyclines . Ann NY Acad Sci732:165-180.
14.
Ryan ME, Greenwald RA, Golub LM (1996). Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr Opin Rheumatol8:238-247.
15.
Seftor Reb, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E., et al. (1992). Role of the αvβ3 integrin in human melanoma cell invasion. Proc Natl Acad
16.
Sci USA89:1557-1561.
17.
Seftor Reb, Seftor EA, Stetler-Stevenson WG, Hendrix Mjc (1993). The 72 kDa type IV collagenase is modulated via differential expression of αvβ3 and α5β1 integrins during human melanoma cell invasion. Cancer Res53:3411-3415.
18.
Smith GN Jr, Brandt KD, Hasty KA (1994). Procollagenase is reduced to inactive fragments upon activation in the presence of doxycycline. Ann NY Acad Sci732:436-438.
19.
Smith GN Jr, Brandt KD, Hasty KA (1996). Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity, Arthrit Rheum39:235-244.
20.
Sorsa T., Konttinen YT, Lindy 0, Suomalainen K., Ingman T., Saari H., et al. (1993). Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase. Agents Actions39(Suppl):225-229.
21.
Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J7:1434-1441.
22.
Stetler-Stevenson WG, Hewitt R., Corcoran M. (1996). Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Sem Cancer Biol7:147-154.
23.
Thorgeirsson UP, Lindsay CK, Cottam DW, Gomez DE (1993). Tumor invasion, proteolysis, and angiogenesis . J Neuro-Oncol18:89-103.
24.
Welch DR, Bisi JE, Miller BE, Conaway D., Seftor EA, Yobem KH, et al. (1991). Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer47:227-237.
25.
Yeatman TJ, Nicolson GL (1993). Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Sem Surg Oncol9:256-263.
26.
Yu M., Sato H., Thompson EW (1995). Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-321 human breast cancer cells.Cancer Res55:3272-3277.
27.
Yu Z., Leung MK, Ramamurthy NS, McNamara TF, Golub LM (1992). HPLC determination of a chemically modified nonantimicrobial tetracycline: biological implications. Biochem Med Metab Biol47:10-20.
28.
Zucker S., Lysik RM, Ramamurthy NS, Golub LM, Wieman JM, Wilkie DP (1985). Diversity of melanoma plasma membrane proteinases: inhibition of collagenolytic and cytolytic activities by minocycline. J Natl Cancer Inst75:517-525.
29.
Zucker S., Wieman J., Lysik RM, Imhof B., Nagase H., Ramamurthy N., et al. (1989). Gelatin-degrading type IV collagenase isolated from human small cell lung cancer. Inv Metast9:167-181.
